| Product Code: ETC6755452 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Transarterial Chemoembolization (TACE) Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Transarterial Chemoembolization (TACE) Market Revenues & Volume, 2021 & 2031F |
3.3 China Transarterial Chemoembolization (TACE) Market - Industry Life Cycle |
3.4 China Transarterial Chemoembolization (TACE) Market - Porter's Five Forces |
3.5 China Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Procedure Type, 2021 & 2031F |
3.6 China Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 China Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 China Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Transarterial Chemoembolization (TACE) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of liver cancer in China |
4.2.2 Growing awareness about the effectiveness of transarterial chemoembolization (TACE) as a treatment option |
4.2.3 Technological advancements in TACE procedures and equipment |
4.2.4 Government initiatives to improve cancer treatment facilities and access to healthcare services |
4.3 Market Restraints |
4.3.1 High cost associated with TACE procedures |
4.3.2 Limited availability of skilled healthcare professionals trained in performing TACE |
4.3.3 Stringent regulatory requirements for TACE procedures |
4.3.4 Potential side effects and complications associated with TACE treatments |
5 China Transarterial Chemoembolization (TACE) Market Trends |
6 China Transarterial Chemoembolization (TACE) Market, By Types |
6.1 China Transarterial Chemoembolization (TACE) Market, By Procedure Type |
6.1.1 Overview and Analysis |
6.1.2 China Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Procedure Type, 2021- 2031F |
6.1.3 China Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Conventional TACE, 2021- 2031F |
6.1.4 China Transarterial Chemoembolization (TACE) Market Revenues & Volume, By DEB-TACE, 2021- 2031F |
6.2 China Transarterial Chemoembolization (TACE) Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 China Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Unresectable HCC, 2021- 2031F |
6.2.3 China Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Early-Stage HCC, 2021- 2031F |
6.3 China Transarterial Chemoembolization (TACE) Market, By Product Type |
6.3.1 Overview and Analysis |
6.3.2 China Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Chemotherapeutic Agents, 2021- 2031F |
6.3.3 China Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Radiotherapeutic Agents, 2021- 2031F |
6.3.4 China Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Drug-eluting Particles, 2021- 2031F |
6.3.5 China Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Transarterial Chemoembolization (TACE) Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 China Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 China Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 China Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Surgical Centers, 2021- 2031F |
6.4.5 China Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Others, 2021- 2031F |
7 China Transarterial Chemoembolization (TACE) Market Import-Export Trade Statistics |
7.1 China Transarterial Chemoembolization (TACE) Market Export to Major Countries |
7.2 China Transarterial Chemoembolization (TACE) Market Imports from Major Countries |
8 China Transarterial Chemoembolization (TACE) Market Key Performance Indicators |
8.1 Average waiting time for TACE procedures |
8.2 Success rate of TACE treatments in terms of tumor response |
8.3 Number of hospitals offering TACE services |
8.4 Patient satisfaction with TACE treatment outcomes |
8.5 Adoption rate of TACE procedures compared to traditional treatment methods |
9 China Transarterial Chemoembolization (TACE) Market - Opportunity Assessment |
9.1 China Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Procedure Type, 2021 & 2031F |
9.2 China Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 China Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.4 China Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Transarterial Chemoembolization (TACE) Market - Competitive Landscape |
10.1 China Transarterial Chemoembolization (TACE) Market Revenue Share, By Companies, 2024 |
10.2 China Transarterial Chemoembolization (TACE) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here